Teladoc Health, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Teladoc Health, the virtual care leader, reported a net loss of $200.3 million in 2025, a significant improvement from 2024, despite a 2% overall revenue decrease driven by its BetterHelp segment.
NYSE
Teladoc Health's 2024 annual report reveals a mix of strategic progress and financial headwinds, including a significant goodwill impairment charge.
NYSE
10-K: Teladoc Health Amends Executive Severance Agreement and Discloses Director Compensation Program
Teladoc Health files an executive severance agreement amendment and details its non-employee director compensation program, outlining terms for severance, equity awards, and cash retainers.